noscript

News and Announcements

SUDA Investor Presentation

  • Published February 26, 2016 9:54AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

25th February 2016, ASX Announcement

Overview

  • SUDA (ASX: SUD) is a drug delivery company commercialising low-risk pharmaceuticals
  • Extensive proprietary technology, expertise and knowhow in formulating and manufacturing oral sprays
  • Multiple patent families covering approx. 300 widely-used drugs formulated into oral sprays
  • SUDA’s first-in-class oral sprays have demonstrated meaningful advantages vs. standard-of-care tablets in multiple clinical studies
  • Multiple oral sprays for large markets – insomnia, malaria, migraine, erectile dysfunction, chemo-induced nausea

Oro-mucosal delivery | Better patient experience

  • Oral mucosa is the lining of the mouth, richly supplied by blood vessels
  • Oral cavity is ideal for systematic therapy, avoids metabolism in the gut
  • Unique advantages of oral sprays compared to tablets

To view the full Investor Presentation, please click here.

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now